Literature DB >> 21443646

Should the reorganization of addiction-related research across all the National Institutes of Health be structural?--The devil is truly in the details.

Bankole A Johnson1, Robert O Messing, Michael E Charness, John C Crabbe, Mark S Goldman, R Adron Harris, Henry R Kranzler, Mack C Mitchell, Sara Jo Nixon, Edward P Riley, Marc A Schuckit, Kenneth J Sher, Jennifer D Thomas.   

Abstract

The recent proposal to dissolve the National Institute on Alcohol Abuse and Alcoholism and National Institute on Drug Abuse and create a new institute for substance use, abuse, and addiction will require significant effort by the staff of both institutes, the Advisory Councils, and outside experts to overcome complex challenges that could threaten its success. Although integration of the grants portfolios can be achieved, harmonization of goals and policies related to legal use of alcohol versus illegal consumption of drugs will present serious challenges. Consolidating the infrastructure of the 2 existing institutes would entail avoiding encroachment on grant funding. A new institute for substance use, abuse, and addiction would require an enormous amount of cooperation from other institutes as the portfolios of research on alcohol, tobacco, and other drug abuse should logically be transferred to the new institute. In the near term, a structural reorganization would be less efficient and more costly than the individual institutes are currently. Increasing efficiency and reducing costs over time will necessitate careful strategic planning. Success in this difficult task would be made easier and less costly by first implementing carefully placed building blocks of increasing functional reorganization. The newly created institute should increase opportunities for specialization within disorders of addiction, attract new leadership, and build a novel strategic plan that will energize scientists and staff and incorporate ideas of stakeholders to advance the public good in preventing and treating alcohol, tobacco, and all addictions. Attention must be paid to the devil in the details.
Copyright © 2011 by the Research Society on Alcoholism.

Entities:  

Mesh:

Year:  2011        PMID: 21443646      PMCID: PMC3068603          DOI: 10.1111/j.1530-0277.2011.01493.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  11 in total

1.  Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study.

Authors:  D A Regier; M E Farmer; D S Rae; B Z Locke; S J Keith; L L Judd; F K Goodwin
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

2.  Drug harms in the UK: a multicriteria decision analysis.

Authors:  David J Nutt; Leslie A King; Lawrence D Phillips
Journal:  Lancet       Date:  2010-10-29       Impact factor: 79.321

3.  Plasticity of reward neurocircuitry and the 'dark side' of drug addiction.

Authors:  George F Koob; Michel Le Moal
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

Review 4.  Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies.

Authors:  Philip A May; J Phillip Gossage; Wendy O Kalberg; Luther K Robinson; David Buckley; Melanie Manning; H Eugene Hoyme
Journal:  Dev Disabil Res Rev       Date:  2009

5.  Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders.

Authors:  Jürgen Rehm; Colin Mathers; Svetlana Popova; Montarat Thavorncharoensap; Yot Teerawattananon; Jayadeep Patra
Journal:  Lancet       Date:  2009-06-27       Impact factor: 79.321

6.  Disaggregating the burden of substance dependence in the United States.

Authors:  Bridget F Grant; Deborah A Dawson; Howard B Moss
Journal:  Alcohol Clin Exp Res       Date:  2011-02-11       Impact factor: 3.455

7.  A double-blind, placebo-controlled trial combining sertraline and naltrexone for treating co-occurring depression and alcohol dependence.

Authors:  Helen M Pettinati; David W Oslin; Kyle M Kampman; William D Dundon; Hu Xie; Thea L Gallis; Charles A Dackis; Charles P O'Brien
Journal:  Am J Psychiatry       Date:  2010-03-15       Impact factor: 18.112

Review 8.  Medication treatment of different types of alcoholism.

Authors:  Bankole A Johnson
Journal:  Am J Psychiatry       Date:  2010-06       Impact factor: 18.112

9.  Efficacy of Crude Marijuana and Synthetic Delta-9-Tetrahydrocannabinol as Treatment for Chemotherapy-Induced Nausea and Vomiting: A Systematic Literature Review.

Authors:  Jayme Cotter
Journal:  Oncol Nurs Forum       Date:  2009-05-01       Impact factor: 2.172

10.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08
View more
  1 in total

1.  How Should Addiction-Related Research at the National Institutes of Health be Reorganized?

Authors:  Bankole A Johnson; Robert O Messing; Michael E Charness; John C Crabbe; Mark S Goldman; R Adron Harris; Henry R Kranzler; Mack C Mitchell; Sara Jo Nixon; Edward P Riley; Marc A Schuckit; Kenneth J Sher; Jennifer D Thomas
Journal:  Front Psychiatry       Date:  2011-05-03       Impact factor: 4.157

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.